Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 487

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial

Open access
Marenzi, G., Bartorelli, A. L.·2007·European Heart Journal

Abstract

We read with great interest the recent article by Schächinger et al.1 showing improved 1 year clinical outcomes in patients with acute myocardial infarction receiving intracoronary administration of bone marrow-derived progenitors cells (BMCs) after successful reperfusion therapy. The authors attribute the improved clinical outcomes in the treatment group to the recovery of global left ventricular contractile function within 4 months, as recently reported in the same patient population.2 However, we believe that factors other than administration of BMCs may have influenced left ventricular ejection fraction (LVEF) recovery and, hence, clinical outcomes in their study. First, we can suppose that spontaneous LVEF recovery was already occurring in both groups before BMCs or placebo administration. Indeed, baseline LVEF was 46.7 ± 10 and 47.5 ± 10% in controls and BMC-treated patients, respectively—values higher than that used as a threshold for patient inclusion in the study (≤45%). This spontaneous recovery may be explained by the mean delay between enrolment and baseline LVEF measurement (4.3 ± 1.3 days). Secondly, and more importantly, two major determinants of LVEF recovery—time-to-reperfusion and infarct location—are possible confounders in this study. According to Sheiban et al.,3 LVEF recovery is usually observed after primary angioplasty if coronary flow is restored ≤4 h from symptom onset, whereas no significant improvement occurs afterwards. This time “window” may be even narrower in anterior infarctions. Indeed, we have observed no significant recovery in LVEF after primary angioplasty despite an average shorter time-to- reperfusion (2.5 ± 1.4 h) when only anterior myocardial infarctions were considered.4 In the REPAIR-AMI study, however, the authors analysed anterior and inferior infarctions together, despite the fact that these two infarct locations differ in terms of acute left ventricular impairment severity, LVEF recovery and clinical outcome after reperfusion therapy.5,6 In BMC-treated patients, anterior infarctions were less represented (64 vs. 76%), which may explain the small difference in LVEF recovery between the placebo and treated groups (3.0 ± 6.5 vs. 5.5 ± 7.3%), and in clinical outcomes.1,2 Moreover, mean reperfusion time was ≥7 h, an interval usually not associated with LVEF improvement, particularly in anterior infarctions.3,4 The combination of different times to treatment and infarct locations may have a major influence on LVEF recovery and long-term event rate. It is surprising that these two critical factors were not taken into account among the variety of covariates considered by the authors. Thus, we believe that the LVEF changes and clinical outcomes should be re-analysed after adjustment for infarct location and time-to-reperfusion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehm257

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 487

Metadata

Authors
Marenzi, G., & Bartorelli, A. L.
Venue
European Heart Journal
Published
2007-07-19
Volume
28
Issue
17
Pages
2172-2173
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2146159580
Cited by
487
References
23
FWCI
30.75
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. https://app.cochat.ai/papers/10.1093/eurheartj/ehm257
The paper
Marenzi, G., & Bartorelli, A. L. (2007). Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehm257

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.